SEC Form 4 research
| Issuer | IOVANCE BIOTHERAPEUTICS, INC. |
|---|---|
| Tickers | IOVA, LBIO, GNBP.OB, GNBP, FGGT, GNPB |
| Reporting owners | 49 |
| Officers and directors | 11 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-09-30 | Berkowitz Noah | A | 135,000 | $0 | Not reported |
| 2026-10-02 | 2026-09-30 | Berkowitz Noah | A | 180,000 | $0 | Not reported |
| 2026-10-02 | 2026-09-30 | Berkowitz Noah | A | 135,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.